X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (67) 67
pharmacology & pharmacy (57) 57
rats (41) 41
animals (40) 40
humans (37) 37
male (37) 37
rats, wistar (17) 17
colorectal cancer (15) 15
pharmacokinetics (13) 13
rats, inbred strains (13) 13
decitabine (12) 12
in vitro techniques (10) 10
drug interaction (9) 9
superoxide dismutase - genetics (9) 9
cell line, tumor (8) 8
female (8) 8
vitamin k 2 - analogs & derivatives (8) 8
warfarin (8) 8
chemistry, multidisciplinary (7) 7
epidermal growth factor (7) 7
expression (7) 7
gene therapy (7) 7
invasion (7) 7
menatetrenone (7) 7
metabolism (7) 7
parenteral drug-delivery (7) 7
protease inhibitor (7) 7
superoxide dismutase (7) 7
transfection (7) 7
adult (6) 6
cancer (6) 6
cells (6) 6
dna methylation (6) 6
emulsions (6) 6
intravenous-injection (6) 6
oxaliplatin (6) 6
particle size (6) 6
tissue distribution (6) 6
vitamin k 2 - pharmacokinetics (6) 6
aspirin (5) 5
bioavailability (5) 5
carriers (5) 5
cell survival - drug effects (5) 5
cells, cultured (5) 5
cytotoxicity (5) 5
drugs (5) 5
ethanol (5) 5
genetic therapy (5) 5
guanidines - pharmacology (5) 5
hemostatics - administration & dosage (5) 5
human serum albumin (5) 5
in-vitro (5) 5
injections, intravenous (5) 5
insulin (5) 5
k tu pharmacology & pharmacy (5) 5
kinetics (5) 5
lines (5) 5
mechanism (5) 5
microrna (5) 5
nafamostat (5) 5
ointments (5) 5
oxyethylene (5) 5
rat (5) 5
secretin (5) 5
soybean oil - chemistry (5) 5
stereoisomerism (5) 5
toxicity (5) 5
vitamin k 2 - administration & dosage (5) 5
acetylation (4) 4
aged (4) 4
antineoplastic agents - pharmacology (4) 4
azacitidine - analogs & derivatives (4) 4
azacitidine - pharmacology (4) 4
base sequence (4) 4
cell membrane - metabolism (4) 4
chemistry (4) 4
chromatography, high pressure liquid (4) 4
colorectal neoplasms - drug therapy (4) 4
degradation (4) 4
dna methyltransferase inhibitor (4) 4
dna modification methylases - antagonists & inhibitors (4) 4
doxorubicin - analogs & derivatives (4) 4
doxorubicin - pharmacokinetics (4) 4
drug interactions (4) 4
drug metabolism (4) 4
effect (4) 4
epidermal growth factor - metabolism (4) 4
epidermal growth factor - pharmacology (4) 4
epigenetics (4) 4
epithelial-mesenchymal transition (4) 4
gastric mucosa - metabolism (4) 4
gene expression (4) 4
half-life (4) 4
hemostatics - pharmacokinetics (4) 4
histone deacetylase inhibitor (4) 4
inhibitors (4) 4
iodine radioisotopes (4) 4
irinotecan (4) 4
liposomes (4) 4
middle aged (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018, Volume 41, Issue 2, pp. 277 - 280
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 8, pp. 1320 - 1325
Journal Article
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2016, Volume 39, Issue 8, pp. 1364 - 1369
Human serum albumin (HSA) has two major ligand-binding sites, sites I and II, and also hydrolyzes some compounds at both sites. In the present study, we... 
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2014, Volume 37, Issue 1, pp. 67 - 73
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2015, Volume 38, Issue 9, pp. 1272 - 1279
The effects of decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor, on metastasis and exosomal expression of microRNAs were examined in SW620/OxR cells,... 
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2015, Volume 38, Issue 8, pp. 1113 - 1119
DNA hypermethylation, an epigenetic change that silences gene expression without altering nucleotide sequences, plays a critical role in the formation and... 
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 8, pp. 1320 - 1325
The effects of zebularine, a DNA methyltransferase inhibitor, on the invasion activity as well as intracellular expression level of let-7b, tumor suppressor... 
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018
Human serum albumin (HSA) has two major ligand-binding sites, sites I and II, and hydrolyzes compounds at both sites. Although the hydrolytic interaction of... 
drug interaction | olmesartan medoxomil | aspirin | human serum albumin | ethanol | hydrolysis
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017
Limited information is currently available on how to apply epigenetic modifiers to current colorectal cancer (CRC) chemotherapy. The purpose of this study is... 
DNA methyltransferase inhibitor | colorectal cancer | histone deacetylase inhibitor | schedule-dependent treatment | epigenetic therapy
Journal Article
Diabetology International, ISSN 2190-1678, 3/2017, Volume 8, Issue 1, pp. 39 - 44
We studied the usefulness of glycated albumin (GA) for decisions regarding the discontinuation of a diabetes drug in type 2 diabetic patients with good... 
Glycated albumin | Diabetes drug | Discontinuation | Medicine & Public Health | Metabolic Diseases | Type 2 diabetes mellitus | Diabetes | HbA1c | Endocrinology | Autoimmune diseases | Diabetes mellitus | Immunology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.